a prefilled sodium hyaluronate injection (non-crosslinked HA, 25 mg/2.5 mL = 10 mg/mL) designed for superficial intradermal delivery using the nappage or microdroplet technique. Each prefilled syringe contains 2.5 mL — enough for a full-face treatment. The injection protocol targets the papillary dermis at 1–2 mm depth, distributing small volumes (0.02–0.05 mL per point) across treatment zones. Hyaron can also be delivered via microneedling for broader coverage with less practitioner time. A standard course is 3 sessions spaced 2–4 weeks apart, with results lasting 3–4 months on the face.

Hyaron contains non-crosslinked sodium hyaluronate at a concentration of 10 mg/mL (25 mg total per 2.5 mL syringe) — identical in molecular structure to the hyaluronic acid naturally present in human skin. The molecular weight is approximately 1,000 kDa, and the solution is isotonic with human tissue. “Non-crosslinked” means the HA molecules are free-form rather than chemically bonded together, which is what distinguishes Hyaron from volumizing fillers like Juvederm or Restylane.